K
Kimia Biosciences
KIMIABL Share Price
Healthcare27.76
as on 13 Mar 2026 at 15:57
BSE
Market Cap
₹131 Cr
PE Ratio
15.70
ROCE
61.90%
KIMIABL Fundamentals
Company Valuation
Market Cap (₹ Cr.)
131
PE Ratio
15.70
PB Ratio
12.25
Dividend Yield
-
ROE
96.45%
ROCE
61.90%
Book Value (₹)
2.45
Face Value (₹)
1.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 74.94% | 74.94% | 74.94% | 74.94% | 74.94% |
| Domestic Institutional Investors (DII) | 0.38% | 0.38% | 0.38% | 0.38% | 0.38% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 22.94% | 23.04% | 23.04% | 22.93% | 22.92% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
KIMIABL Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
530313
NSE Scrip Name
KIMIABL
ISIN
INE285U01025



